References
- Effexor XR. package insert. Wyeth Pharmaceuticals Inc, Philadelphia, PA August, 2006
- Richelson E. Pharmacology of antidepressants. Mayo Clin Proc 2001; 76: 511–527
- Rudolph RL, Derivan AT. The safety and tolerability of venlafaxine hydrochloride: Analysis of the clinical trials database. J Clin Psychopharmacol 1996; 16(3 suppl 2)54–61
- Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB. Antidepressant biochemical profile of the novel bicyclic compound Wy-45, 030, an ethyl cyclohexanol derivative. Biochemical Pharmacology 1986; 35(24)4493–7
- Dunkley EJC, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. Q J Med 2003; 96: 635–642
- Benazzi F. Venlafaxine-fluoxetine interaction [Case Reports Letter]. Journal of Clinical Psychopharmacology 1999; 19(1)96–8
- Benazzi F. Anticholinergic toxic syndrome with venlafaxine-desipramine combination [comment]. Pharmacopsychiatry 1998; 31(1)36–7
- www.rxmed.com, Rx Med. Drug and illness information. Pharmaceutical Information-Effexor.